Incubator Webinar: Regulation of LLMs
‘How to get regulatory approval for an LLM-enabled medical device’:
Presented by Dr Hugh Harvey
Presented by Dr Hugh Harvey
When: Monday 18th March 2024 4-5pm GMT
Where: Online, via Zoom
Who should attend? Healthcare professionals, AI developers, clinical researchers, or anyone else interested!
Request the recording: ai.incubator@uhb.nhs.uk
Join a community of researchers, practitioners, industry and others across the AI health technology landscape for a presentation and discussion with Dr Hugh Harvey, Managing Director of Hardian Health.
What is an LLM? Large language models, or LLMs, are a type of artificial intelligence that have taken in very large amounts of text to allow them to make new text by predicting sequences of words. Examples include ChatGPT and Bard.
Why should I care? In a short time, LLMs have already become part of many people’s routine work. Using LLMs has often improved the speed people can do certain tasks at and sometimes how well they can do them.
Does it impact healthcare? Not yet. There has been lots of interest and investment in getting LLMs to improve healthcare, but it has not been done before and people responsible for their use will have to deal with new challenges, including regulation.
Get ready to explore:
What makes LLMs distinct from other AI as a medical device
The practical steps that a LLM-enabled medical device vendor would need to take to get approval
The key barriers to gaining approval
Request the recording: ai.incubator@uhb.nhs.uk
Find out more about Dr Hugh Harvey below @DrHughHarvey
Dr Harvey is an ex-NHS consultant radiologist and academic, trained at the Institute of Cancer Research, twice awarded ICR Science Writer of the Year.
He is a prior member of the RCRs informatics and AI committees, a lifetime Fellow of the Royal College of Radiologists and is an honorary fellow of the British Institute of Radiology. He also holds an honorary academic position at the University of Birmingham. He acted as co-chair to the UK Topol Health Technology Review for Health Education England, and is an advisor to the Medicines & Healthcare products Regulatory Agency.
After leaving NHS medicine and academia he worked at Babylon Health where he gained world-first regulatory approval for an AI-enabled chatbot, and then became medical director at Kheron Medical gaining EU-first CE marking for a Class IIb breast cancer screening AI software. He is globally regarded as a top clinical regulatory expert for software and AI devices.
Managing Director at Hardian Health since 2018, he has built a specialist global consultancy focussed on software as a medical device regulatory, clinical, health economics, market strategy and intellectual property services.
This event is being delivered by the NIHR-supported Incubator for AI and Digital Healthcare, hosted by the University Hospitals Birmingham NHS FT.
